Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932.
Saved in:
| Title: | Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932. |
|---|---|
| Authors: | Balsamo LM; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA., Kairalla JA; Department of Biostatistics, Colleges of Medicine and Public Health & Health Professions, University of Florida, Gainesville, Florida, USA., Hibbitts E; Department of Biostatistics, Colleges of Medicine and Public Health & Health Professions, University of Florida, Gainesville, Florida, USA., Rodwin RL; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA., Devidas M; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Dreyzin A; Pediatric Oncology Branch, National Cancer Institute and Center for Cellular Engineering, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Winick NJ; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Carroll WL; Perlmutter Cancer Center and Department of Pediatrics, NYU Langone Medical Center, New York, New York, USA., Hunger SP; Department of Pediatrics, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Raetz EA; Perlmutter Cancer Center and Department of Pediatrics, NYU Langone Medical Center, New York, New York, USA., Schore RJ; Pediatric Oncology Branch, National Cancer Institute and Center for Cellular Engineering, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.; Department of Pediatrics and Clinical and Translational Oncology Program, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA., Loh ML; Ben Towne Center for Childhood Cancer Research, Seattle Children's Hospital, Seattle, Washington, USA., Ness KK; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Angiolillo AL; Servier Pharmaceuticals, Boston, Massachusetts, USA., Kadan-Lottick NS; Georgetown University Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA. |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2026 Mar; Vol. 73 (3), pp. e70029. Date of Electronic Publication: 2026 Jan 05. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
